StreetAlpha
13F holdings · Q3 2026

Exor N.V.

Amsterdam, P7 · files as Exor N.V.
Know the moment Exor N.V. filesYou follow Exor N.V. An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1589122

Exor N.V. reported 6 stocks worth $22.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are RACE (67.3%), CNH (21.4%) and STLA (8.9%).

Latest filing: what Exor N.V. did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
0 new0 added0 trimmed0 sold outBought about $0 · sold about $0
New 0

None

Added 0

None

Trimmed 0

None

Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$22.1B+4.2% vs last quarter
Stocks held60 new · 0 sold out
Top 5 weight100.0%very concentrated
Turnover0%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
RACE
Ferrari N V
$14.8B67.3%37.8MNo change8 of 8
2
CNH
Cnh Indl N V
$4.7B21.4%367MNo change8 of 8
3
STLA
Stellantis NV
$2B8.9%449MNo change8 of 8
4
VIA
Via Transn Inc
$427M1.9%14.1MNo change5 of 8
5
CLVT
Clarivate PLC
$112M0.5%67.3MNo change8 of 8
6
NMRA
Neumora Therapeutics Inc.
$2.5M0.0%4.2MNo change8 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$29.3BQ4 '24
$26BQ1 '25
$28.1BQ2 '25
$27.4BQ3 '25
$22.9BQ4 '25
$20.4BQ1 '26
$21.2BQ2 '26
$22.1BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Exor N.V. 13F FAQ

What does Exor N.V. own?

Exor N.V. reported 6 stocks worth $22.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. The table above lists every position in the filing (the top 10 without an account).

What did Exor N.V. buy and sell in Q3 2026?

Compared with Q2 2026: 0 new positions, 0 added to, 0 trimmed and 0 sold out.

When will Exor N.V. file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Exor N.V.'s portfolio worth?

The Q3 2026 filing reports $22.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.